Biogen Idec and its newly named in-house expert Olivier Danos have executed a research deal with the San Raffaele-Telethon Institute for Gene Therapy to develop what they believe promises to be a durable treatment for hemophilia.

…read more

Source: Biogen Idec quietly carves out a leading role in developing gene therapy for hemophilia